Anyone think it's a coincidence that it is going to take management until June to submit a request for more information to the FDA regarding sleepcheck.
I mean it's a dogshit app anyway and they have obviously failed once again to provide enough evidence or correct evidence it works in the first submission to get it passed.
But if it had of been given FDA approval on first submission that would add value to the company. Perhaps another unnamed company with a certain amount of pull with FDA didn't like that.
- Forums
- ASX - By Stock
- RAP
- Ann: Quarterly Activities Report and Appendix 4C
Ann: Quarterly Activities Report and Appendix 4C, page-81
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
Featured News
Add RAP (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online